CG
CDNA icon

Cutler Group’s CareDx CDNA Stock Holding History

Cutler Group’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$2.77K – 5020
2022
Q1 		$3K Buy
+100
New +$3.9K ﹤0.01% 4421
2021
Q2 		– Sell
-539
Closed -$36K – 5731
2021
Q1 		$36K Buy
539
+500
+1,282% +$38.8K ﹤0.01% 2682
2020
Q4 		$2K Sell
39
-200
-84% -$11.6K ﹤0.01% 4115
2020
Q3 		$9K Sell
239
-361
-60% -$12.2K ﹤0.01% 3052
2020
Q2 		$21K Buy
+600
New +$17.1K ﹤0.01% 2344
2019
Q4 		– Sell
-800
Closed -$18K – 4027
2019
Q3 		$18K Buy
+800
New +$22.2K ﹤0.01% 2242
2019
Q2 		– Sell
-1,400
Closed -$44.8K – 4260
2019
Q1 		$44K Buy
1,400
+800
+133% +$23.3K ﹤0.01% 1509
2018
Q4 		$15K Hold
600
– – ﹤0.01% 2290
2018
Q3 		$17K Buy
+600
New +$11.2K ﹤0.01% 2332

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cutler Group's CDNA Position: Q2 2022 in Review

Cutler Group sold out of CareDx (CDNA) in Q2 2022, closing a stake of 100 shares — an estimated $2.77K sold.

Cutler Group first reported a position in CDNA in Q3 2018 and held it in 9 quarters. The position peaked at $44K in Q1 2019. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Cutler Group reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 100 CareDx shares in Q2 2022, an estimated $2.77K.
  • Cutler Group first reported a position in CareDx in Q3 2018 and held it in 9 quarters.
  • Cutler Group's CareDx position peaked at $44K in Q1 2019.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.